Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
PLoS One. 2013 Jul 23;8(7):e68916. doi: 10.1371/journal.pone.0068916. Print 2013.
Existing approaches that quantify cytotoxic T cell responses rely on bulk or surrogate measurements which impede the direct identification of single activated T cells of interest. Single cell microscopy or flow cytometry methodologies typically rely on fluorescent labeling, which limits applicability to primary cells such as human derived T lymphocytes. Here, we introduce a quantitative method to track single T lymphocyte mediated cytotoxic events within a mixed population of cells using live cell interferometry (LCI), a label-free microscopy technique that maintains cell viability. LCI quantifies the mass distribution within individual cells by measuring the phase shift caused by the interaction of light with intracellular biomass. Using LCI, we imaged cytotoxic T cells killing cognate target cells. In addition to a characteristic target cell mass decrease of 20-60% over 1-4 h following attack by a T cell, there was a significant 4-fold increase in T cell mass accumulation rate at the start of the cytotoxic event and a 2-3 fold increase in T cell mass relative to the mass of unresponsive T cells. Direct, label-free measurement of CD8+ T and target cell mass changes provides a kinetic, quantitative assessment of T cell activation and a relatively rapid approach to identify specific, activated patient-derived T cells for applications in cancer immunotherapy.
现有的量化细胞毒性 T 细胞反应的方法依赖于批量或替代测量,这阻碍了对感兴趣的单个活化 T 细胞的直接识别。单细胞显微镜或流式细胞术方法通常依赖于荧光标记,这限制了其在原代细胞(如人类来源的 T 淋巴细胞)中的应用。在这里,我们引入了一种使用活细胞干涉测量(LCI)的定量方法,在混合细胞群中跟踪单个 T 淋巴细胞介导的细胞毒性事件,LCI 是一种无标记显微镜技术,可保持细胞活力。LCI 通过测量光与细胞内生物质相互作用引起的相移来量化单个细胞内的质量分布。使用 LCI,我们对细胞毒性 T 细胞杀伤同源靶细胞进行了成像。除了在 T 细胞攻击后 1-4 小时内靶细胞质量特征性减少 20-60%之外,在细胞毒性事件开始时 T 细胞的质量积累率显著增加了 4 倍,并且 T 细胞的质量相对于无反应性 T 细胞的质量增加了 2-3 倍。CD8+T 细胞和靶细胞质量变化的直接、无标记测量提供了 T 细胞活化的动力学、定量评估,并且是一种相对快速的方法,可以识别特定的、活化的患者来源的 T 细胞,用于癌症免疫治疗。